Of course, as Dream continued its climb back to the top, Julius had not remained idle either. Operations had begun months prior, and his own company, SIBYL, had risen through the stock market with unprecedented speed.
In just two months of being publicly listed, it had already broken through barriers that most companies needed years to reach.
Unlike in the past, where SIBYL had been used as an overseer and a tool for surveillance, this time the company's direction was different.
The unique cognitive functions that defined SIBYL's systems were now being applied to fields that desperately needed them.
Mental health institutes had adopted SIBYL's therapeutic programs. Asylum facilities benefited from the AI's ability to stabilize patients who could not be reached by traditional methods.
SIBYL, which had once been a weapon, had become a lifeline.
